STK-1, THE HUMAN HOMOLOG OF FLK-2/FLT-3, IS SELECTIVELY EXPRESSED IN CD34(+) HUMAN BONE-MARROW CELLS AND IS INVOLVED IN THE PROLIFERATION OF EARLY PROGENITOR STEM-CELLS

被引:395
作者
SMALL, D
LEVENSTEIN, M
KIM, E
CAROW, C
AMIN, S
ROCKWELL, P
WITTE, L
BURROW, C
RATAJCZAK, MZ
GEWIRTZ, AM
CIVIN, CI
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21287 USA
[2] JOHNS HOPKINS UNIV, SCH MED, DEPT NEPHROL, BALTIMORE, MD 21287 USA
[3] UNIV PENN, SCH MED, DEPT LAB MED, PHILADELPHIA, PA 19104 USA
[4] UNIV PENN, SCH MED, DEPT PATHOL, PHILADELPHIA, PA 19104 USA
[5] UNIV PENN, SCH MED, DEPT MED, PHILADELPHIA, PA 19104 USA
[6] IMCLONE SYST INC, NEW YORK, NY 10014 USA
关键词
GROWTH FACTOR RECEPTOR; TYROSINE KINASE; HEMATOPOIESIS; ANTISENSE;
D O I
10.1073/pnas.91.2.459
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We cloned the cDNA for stem cell tyrosine kinase 1 (STR-1), the human homolog of murine Flk-2/Flt-3, from a CD34(+) hematopoietic stem cell-enriched library and investigated its expression in subsets of normal human bone marrow. The cDNA encodes a protein of 993 aa with 85% identity and 92% similarity to FLk-2/Flt-3. STK-1 is a member of the type m receptor tyrosine kinase family that includes KIT (steel factor receptor), FMS (colony-stimulating factor 1R), and platelet derived growth factor receptor. STK-1 expression in human blood and marrow is restricted to CD34(+) cells, a population greatly enriched for stem/progenitor cells. Anti-STK-1 antiserum recognizes polypeptides of 160 and 130 kDa in several STK-1 expressing cell lines and in 3T3 cells transfected with a STK-1 expression vector. Antisense oligonucleotides directed against STK-1 sequences inhibited hematopoietic colony formation, most strongly in long-term bone marrow cultures. These data suggest that STK-1 may function as a growth factor receptor on hematopoietic stem and/or progenitor cells.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 39 条
[1]   ANTIGEN CD34+ MARROW-CELLS ENGRAFT LETHALLY IRRADIATED BABOONS [J].
BERENSON, RJ ;
ANDREWS, RG ;
BENSINGER, WI ;
KALAMASZ, D ;
KNITTER, G ;
BUCKNER, CD ;
BERNSTEIN, ID .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (03) :951-955
[2]  
BERENSON RJ, 1991, BLOOD, V77, P1717
[3]  
BIRG F, 1992, BLOOD, V80, P2584
[4]  
BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
[5]   THE PROTO-ONCOGENE C-KIT ENCODING A TRANSMEMBRANE TYROSINE KINASE RECEPTOR MAPS TO THE MOUSE W-LOCUS [J].
CHABOT, B ;
STEPHENSON, DA ;
CHAPMAN, VM ;
BESMER, P ;
BERNSTEIN, A .
NATURE, 1988, 335 (6185) :88-89
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]   CELL-SURFACE ANTIGENS ON HUMAN MARROW-CELLS - DISSECTION OF HEMATOPOIETIC DEVELOPMENT USING MONOCLONAL-ANTIBODIES AND MULTIPARAMETER FLOW-CYTOMETRY [J].
CIVIN, CI ;
LOKEN, MR .
INTERNATIONAL JOURNAL OF CELL CLONING, 1987, 5 (04) :267-288
[8]  
CIVIN CI, 1984, J IMMUNOL, V133, P157
[9]  
CIVIN CI, 1990, PROG CLIN BIOL RES, V333, P387
[10]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13